CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Other acquisition President and CEO acquired 5,236 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP Finance and CFO sold 92,450 shares at an average $0.21 ($19,359)
- 4 Exercise or conversion Director acquired 1,400,000 shares (option exercise)
- 4 Exercise or conversion VP Finance and CFO acquired 280,000 shares (option exercise)
- 4 Other acquisition President and CEO acquired 3,447 shares (other)
- 4 Other acquisition Director acquired 6,894 shares (other)
- 4 Exercise or conversion Director acquired 700,000 shares (option exercise)
- 4 Open-market buy Director bought 24,973 shares at $0.30 ($7,492)
- 4 Open-market buy Director bought 25,000 shares at $0.31 ($7,750)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 19 of 24 · 471 filings